The promise of whole-exome sequencing in medical genetics

Bahareh Rabbani, Mustafa Tekin, Nejat Mahdieh

Research output: Contribution to journalArticle

208 Citations (Scopus)

Abstract

Massively parallel DNA-sequencing systems provide sequence of huge numbers of different DNA strands at once. These technologies are revolutionizing our understanding in medical genetics, accelerating health-improvement projects, and ushering to a fully understood personalized medicine in near future. Whole-exome sequencing (WES) is application of the next-generation technology to determine the variations of all coding regions, or exons, of known genes. WES provides coverage of more than 95% of the exons, which contains 85% of disease-causing mutations in Mendelian disorders and many disease-predisposing SNPs throughout the genome. The role of more than 150 genes has been distinguished by means of WES, and this statistics is quickly growing. In this review, the impacts of WES in medical genetics as well as its consequences leading to improve health care are summarized.

Original languageEnglish
Pages (from-to)5-15
Number of pages11
JournalJournal of Human Genetics
Volume59
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Exome
Medical Genetics
Exons
Technology
High-Throughput Nucleotide Sequencing
Precision Medicine
DNA Sequence Analysis
Genes
Single Nucleotide Polymorphism
Genome
Delivery of Health Care
Mutation
DNA
Health

Keywords

  • Cancer
  • common disease
  • medical genomics
  • Mendelian disorder
  • whole-exome sequencing

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

The promise of whole-exome sequencing in medical genetics. / Rabbani, Bahareh; Tekin, Mustafa; Mahdieh, Nejat.

In: Journal of Human Genetics, Vol. 59, No. 1, 01.01.2014, p. 5-15.

Research output: Contribution to journalArticle

Rabbani, Bahareh ; Tekin, Mustafa ; Mahdieh, Nejat. / The promise of whole-exome sequencing in medical genetics. In: Journal of Human Genetics. 2014 ; Vol. 59, No. 1. pp. 5-15.
@article{9a7d977ba57544e4b1725cc387968410,
title = "The promise of whole-exome sequencing in medical genetics",
abstract = "Massively parallel DNA-sequencing systems provide sequence of huge numbers of different DNA strands at once. These technologies are revolutionizing our understanding in medical genetics, accelerating health-improvement projects, and ushering to a fully understood personalized medicine in near future. Whole-exome sequencing (WES) is application of the next-generation technology to determine the variations of all coding regions, or exons, of known genes. WES provides coverage of more than 95{\%} of the exons, which contains 85{\%} of disease-causing mutations in Mendelian disorders and many disease-predisposing SNPs throughout the genome. The role of more than 150 genes has been distinguished by means of WES, and this statistics is quickly growing. In this review, the impacts of WES in medical genetics as well as its consequences leading to improve health care are summarized.",
keywords = "Cancer, common disease, medical genomics, Mendelian disorder, whole-exome sequencing",
author = "Bahareh Rabbani and Mustafa Tekin and Nejat Mahdieh",
year = "2014",
month = "1",
day = "1",
doi = "10.1038/jhg.2013.114",
language = "English",
volume = "59",
pages = "5--15",
journal = "Journal of Human Genetics",
issn = "1434-5161",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - The promise of whole-exome sequencing in medical genetics

AU - Rabbani, Bahareh

AU - Tekin, Mustafa

AU - Mahdieh, Nejat

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Massively parallel DNA-sequencing systems provide sequence of huge numbers of different DNA strands at once. These technologies are revolutionizing our understanding in medical genetics, accelerating health-improvement projects, and ushering to a fully understood personalized medicine in near future. Whole-exome sequencing (WES) is application of the next-generation technology to determine the variations of all coding regions, or exons, of known genes. WES provides coverage of more than 95% of the exons, which contains 85% of disease-causing mutations in Mendelian disorders and many disease-predisposing SNPs throughout the genome. The role of more than 150 genes has been distinguished by means of WES, and this statistics is quickly growing. In this review, the impacts of WES in medical genetics as well as its consequences leading to improve health care are summarized.

AB - Massively parallel DNA-sequencing systems provide sequence of huge numbers of different DNA strands at once. These technologies are revolutionizing our understanding in medical genetics, accelerating health-improvement projects, and ushering to a fully understood personalized medicine in near future. Whole-exome sequencing (WES) is application of the next-generation technology to determine the variations of all coding regions, or exons, of known genes. WES provides coverage of more than 95% of the exons, which contains 85% of disease-causing mutations in Mendelian disorders and many disease-predisposing SNPs throughout the genome. The role of more than 150 genes has been distinguished by means of WES, and this statistics is quickly growing. In this review, the impacts of WES in medical genetics as well as its consequences leading to improve health care are summarized.

KW - Cancer

KW - common disease

KW - medical genomics

KW - Mendelian disorder

KW - whole-exome sequencing

UR - http://www.scopus.com/inward/record.url?scp=84893252645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893252645&partnerID=8YFLogxK

U2 - 10.1038/jhg.2013.114

DO - 10.1038/jhg.2013.114

M3 - Article

VL - 59

SP - 5

EP - 15

JO - Journal of Human Genetics

JF - Journal of Human Genetics

SN - 1434-5161

IS - 1

ER -